Please provide your email address to receive an email when new articles are posted on . There are few medications dermatologists can prescribe for pyoderma gangrenosum, a complex wound disease.
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results